Annual Net Income
-$409.22 M
+$112.00 M+21.49%
December 31, 2024
Summary
- As of March 6, 2025, ASND annual net profit is -$409.22 million, with the most recent change of +$112.00 million (+21.49%) on December 31, 2024.
- During the last 3 years, ASND annual net income has risen by +$44.62 million (+9.83%).
- ASND annual net income is now -7653.93% below its all-time high of $5.42 million, reached on December 31, 2013.
Performance
ASND Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$41.01 M
+$68.09 M+62.41%
December 31, 2024
Summary
- As of March 6, 2025, ASND quarterly net profit is -$41.01 million, with the most recent change of +$68.09 million (+62.41%) on December 31, 2024.
- Over the past year, ASND quarterly net income has increased by +$76.77 million (+65.18%).
- ASND quarterly net income is now -1436.40% below its all-time high of $3.07 million, reached on December 31, 2013.
Performance
ASND Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$410.21 M
+$52.55 M+11.36%
December 31, 2024
Summary
- As of March 6, 2025, ASND TTM net profit is -$410.21 million, with the most recent change of +$52.55 million (+11.36%) on December 31, 2024.
- Over the past year, ASND TTM net income has increased by +$120.08 million (+22.64%).
- ASND TTM net income is now -13468.84% below its all-time high of $3.07 million, reached on December 31, 2013.
Performance
ASND TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ASND Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.5% | +65.2% | +22.6% |
| 3 y3 years | +9.8% | +65.2% | +22.6% |
| 5 y5 years | -67.7% | +65.2% | +22.6% |
ASND Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +33.5% | at high | +80.7% | at high | +35.9% |
| 5 y | 5-year | -67.7% | +33.5% | at high | +80.7% | -68.1% | +35.9% |
| alltime | all time | -7653.9% | +33.5% | -1436.4% | +80.7% | <-9999.0% | +35.9% |
Ascendis Pharma A/S Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$409.22 M(-21.5%) | -$41.01 M(-62.4%) | -$410.21 M(-11.4%) |
| Sep 2024 | - | -$109.10 M(-7.4%) | -$462.76 M(-12.7%) |
| Jun 2024 | - | -$117.77 M(-17.3%) | -$530.29 M(-2.7%) |
| Mar 2024 | - | -$142.33 M(+52.1%) | -$544.93 M(+4.4%) |
| Dec 2023 | -$521.22 M(-15.3%) | -$93.56 M(-47.0%) | -$521.73 M(-18.5%) |
| Sep 2023 | - | -$176.63 M(+33.4%) | -$640.26 M(+1.0%) |
| Jun 2023 | - | -$132.41 M(+11.2%) | -$633.83 M(+7.8%) |
| Mar 2023 | - | -$119.13 M(-43.8%) | -$588.03 M(-3.6%) |
| Dec 2022 | -$615.03 M(+35.5%) | -$212.09 M(+24.6%) | -$609.73 M(+17.5%) |
| Sep 2022 | - | -$170.20 M(+96.5%) | -$518.95 M(+17.0%) |
| Jun 2022 | - | -$86.62 M(-38.5%) | -$443.48 M(-14.5%) |
| Mar 2022 | - | -$140.82 M(+16.1%) | -$518.81 M(+14.4%) |
| Dec 2021 | -$453.84 M(-5.1%) | -$121.30 M(+28.0%) | -$453.65 M(-8.9%) |
| Sep 2021 | - | -$94.73 M(-41.5%) | -$498.03 M(-8.7%) |
| Jun 2021 | - | -$161.94 M(+114.0%) | -$545.66 M(+11.8%) |
| Mar 2021 | - | -$75.67 M(-54.3%) | -$488.27 M(+1.2%) |
| Dec 2020 | -$478.46 M(+96.0%) | -$165.69 M(+16.4%) | -$482.48 M(+18.9%) |
| Sep 2020 | - | -$142.36 M(+36.2%) | -$405.77 M(+39.3%) |
| Jun 2020 | - | -$104.55 M(+49.6%) | -$291.33 M(+15.2%) |
| Mar 2020 | - | -$69.87 M(-21.5%) | -$252.96 M(+3.7%) |
| Dec 2019 | -$244.07 M | -$88.99 M(+218.7%) | -$244.01 M(+27.4%) |
| Sep 2019 | - | -$27.92 M(-57.8%) | -$191.51 M(-5.7%) |
| Jun 2019 | - | -$66.17 M(+8.6%) | -$203.08 M(+23.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$60.93 M(+67.0%) | -$164.11 M(+6.6%) |
| Dec 2018 | -$153.62 M(+9.5%) | -$36.49 M(-7.6%) | -$154.01 M(-2.4%) |
| Sep 2018 | - | -$39.50 M(+45.2%) | -$157.76 M(-0.2%) |
| Jun 2018 | - | -$27.20 M(-46.5%) | -$158.10 M(-4.0%) |
| Mar 2018 | - | -$50.83 M(+26.3%) | -$164.68 M(+17.1%) |
| Dec 2017 | -$140.31 M(+85.1%) | -$40.24 M(+1.0%) | -$140.64 M(+19.0%) |
| Sep 2017 | - | -$39.83 M(+17.9%) | -$118.14 M(+19.7%) |
| Jun 2017 | - | -$33.78 M(+26.2%) | -$98.68 M(+23.5%) |
| Mar 2017 | - | -$26.78 M(+50.9%) | -$79.91 M(+5.5%) |
| Dec 2016 | -$75.82 M(+107.5%) | -$17.74 M(-12.9%) | -$75.76 M(+6.5%) |
| Sep 2016 | - | -$20.37 M(+35.7%) | -$71.14 M(+20.8%) |
| Jun 2016 | - | -$15.01 M(-33.7%) | -$58.89 M(-2.7%) |
| Mar 2016 | - | -$22.63 M(+72.5%) | -$60.50 M(+66.8%) |
| Dec 2015 | -$36.53 M(+184.4%) | -$13.12 M(+61.5%) | -$36.26 M(+23.2%) |
| Sep 2015 | - | -$8.12 M(-51.1%) | -$29.43 M(+23.0%) |
| Jun 2015 | - | -$16.62 M(-1135.8%) | -$23.93 M(+133.6%) |
| Mar 2015 | - | $1.60 M(-125.5%) | -$10.24 M(-18.3%) |
| Dec 2014 | -$12.84 M(-337.1%) | -$6.29 M(+139.8%) | -$12.54 M(+294.8%) |
| Sep 2014 | - | -$2.62 M(-10.5%) | -$3.18 M(+475.6%) |
| Jun 2014 | - | -$2.93 M(+326.4%) | -$551.70 K(-123.2%) |
| Mar 2014 | - | -$687.70 K(-122.4%) | $2.38 M(-22.4%) |
| Dec 2013 | $5.42 M(+237.1%) | $3.07 M | $3.07 M |
| Dec 2012 | $1.61 M | - | - |
FAQ
- What is Ascendis Pharma A/S annual net profit?
- What is the all time high annual net income for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual net income year-on-year change?
- What is Ascendis Pharma A/S quarterly net profit?
- What is the all time high quarterly net income for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly net income year-on-year change?
- What is Ascendis Pharma A/S TTM net profit?
- What is the all time high TTM net income for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM net income year-on-year change?
What is Ascendis Pharma A/S annual net profit?
The current annual net income of ASND is -$409.22 M
What is the all time high annual net income for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual net profit is $5.42 M
What is Ascendis Pharma A/S annual net income year-on-year change?
Over the past year, ASND annual net profit has changed by +$112.00 M (+21.49%)
What is Ascendis Pharma A/S quarterly net profit?
The current quarterly net income of ASND is -$41.01 M
What is the all time high quarterly net income for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly net profit is $3.07 M
What is Ascendis Pharma A/S quarterly net income year-on-year change?
Over the past year, ASND quarterly net profit has changed by +$76.77 M (+65.18%)
What is Ascendis Pharma A/S TTM net profit?
The current TTM net income of ASND is -$410.21 M
What is the all time high TTM net income for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM net profit is $3.07 M
What is Ascendis Pharma A/S TTM net income year-on-year change?
Over the past year, ASND TTM net profit has changed by +$120.08 M (+22.64%)